Treanda (Bendamustine HCl) for Injection, 100 mg/vial, Single-Dose Vial, Powder for Reconstitution
Treanda (bendamustine hydrochloride) for Injection is supplied as a sterile lyophilized powder in a single-dose vial containing 100 mg of bendamustine HCl. It is an alkylating agent indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. The powder must be reconstituted and further diluted prior to intravenous administration.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Treanda (bendamustine hydrochloride) for Injection is supplied as a sterile lyophilized powder in a single-dose vial containing 100 mg of bendamustine HCl. It is an alkylating agent indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. The powder must be reconstituted and further diluted prior to intravenous administration.
1 vendor
